Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2439-2448
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2439
Table 1 Clinicopathologic characteristics of the patients and hepatic observations, n (%)
Characteristic
Value
Patient (n = 331)
Mean age (yr)157.5 ± 10.9
Sex
        Male236 (71.3)
        Female95 (28.7)
Cause of liver disease
        Hepatitis B virus244 (73.7)
        Hepatitis C virus51 (15.4)
        Hepatitis B and C virus9 (2.7)
        Alcohol10 (3.0)
        Autoimmune4 (1.2)
        NASH3 (0.9)
        Cirrhosis of unknown cause10 (3.0)
Number of observations per patient
        1309 (93.4)
        219 (5.7)
        33 (0.9)
Observation (n = 356)
    Size (mm)1
        Overall31.5 ± 25.9
        HCC35.8 ± 27.1
        Non-HCC malignancy43.2 ± 27.8
        Benign lesion21.0 ± 19.2
    Final diagnosis
        HCC215 (60.4)
        Non-HCC malignancy25 (7.0)
            ICC7 (2.0)
            CHC8 (2.2)
            Metastasis5 (1.4)
            Sarcomatoid carcinoma4 (1.1)
            Neuroendocrine carcinoma1 (0.3)
        Benign lesion116 (32.6)
            Haemangioma14 (3.9)
            DN24 (6.7)
            RN42 (11.8)
            FNH-like17 (4.8)
            Adenoma or adenomatoid hyperplasia5 (1.4)
            Abscess2 (0.6)
            Angiomyolipoma2 (0.6)
            Epithelioid angiomyolipoma3 (0.8)
            Abnormal perfusion7 (2.0)
    Standard reference of diagnosis
        Pathologic diagnosis286 (80.3)
        Typical imaging features and follow-up70 (19.7)
            The time of follow-up (months)132.3 ± 13.5
Table 2 The observation categories according to the liver imaging reporting and data system
LI-RADS category
LI-RADS v2018
sLI-RADS A
sLI-RADS B
sLI-RADS C
sLI-RADS D
F-sLI-RADS
HCC
non-HCC
HCC
non-HCC
HCC
non-HCC
HCC
non-HCC
HCC
non-HCC
HCC
non-HCC
1042042042042042042
2138138138138138138
3111316281211131113713
4151921422266425918614
518714176141901813881931520019
M115115115115115115
Total215141215141215141215141215141215141
Table 3 Diagnostic performance of the liver imaging reporting and data system for hepatocellular carcinoma, %

Sensitivity
Specificity
PPV
NPV
Accuracy
Youden
LI-RADS v201887.090.193.081.988.20.770
sLI-RADS A81.990.192.676.585.10.719
sLI-RADS B88.487.291.383.187.90.756
sLI-RADS C64.293.693.963.275.80.578
sLI-RADS D89.889.492.885.189.60.791
F-sLI-RADS93.086.591.389.190.40.795
aPvalue0.001> 0.9990.001
bPvalue0.2500.125> 0.999
cPvalue< 0.0010.031< 0.001
dPvalue0.031> 0.9990.062
ePvalue< 0.0010.0620.008
fPvalue0.0160.1250.250